Latest Breaking News On - Alto neuroscience inc - Page 1 : comparemela.com

Alto Neuroscience (NYSE:ANRO) Stock Rating Reaffirmed by William Blair

Alto Neuroscience (NYSE:ANRO – Get Free Report)‘s stock had its “outperform” rating reiterated by investment analysts at William Blair in a research report issued on Wednesday, RTT News reports. Several other research firms also recently weighed in on ANRO. Robert W. Baird started coverage on shares of Alto Neuroscience in a research report on Tuesday, […]

United-states
Texas
Nicholas-conrad-smith
Robertw-baird
William-blair
Stifel-nicolaus
Alto-neuroscience-company-profile
Alto-neuroscience-inc
Jennison-associates
Jefferies-financial-group
Artal-group
Investment-company-inc

Alto Neuroscience to Present at the Jefferies Global Healthcare Conference

Alto Neuroscience, Inc. today announced that Company management will participate in the Jefferies Global Healthcare Conference, taking place June 5-6, 2024, in New York. Amit Etkin, M.D., Ph.D.,.

New-york
United-states
Amit-etkin
Alto-neuroscience-inc
Alto-neuroscience
Jefferies-global-healthcare-conference
Precision-psychiatry-platform

Alto Neuroscience Announces Data Presentations Highlighting Late-Stage Clinical Pipeline and Robust Platform at Upcoming Scientific Conferences

Alto Neuroscience Announces Data Presentations Highlighting Late-Stage Clinical Pipeline and Robust Platform at Upcoming Scientific Conferences
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United-states
Texas
Toronto
Ontario
Canada
San-francisco
California
American
John-sonnenberg
Cherise-chin-fatt
Adam-savitz
Samanthav-goncalves

MEDRx : Collaboration Partner, Alto Neuroscience, Announces Positive Phase 1 Results for ALTO-101, a Novel PDE4 Inhibitor in Development for Schizophrenia

News Release Dated April 24, 2024 MedRx Co., Ltd. Yonehiro Matsumura, CEO Stock code: 4586, TSE Growth .

Yonehiro-matsumura
Medrx-co-ltd
Management-department
Inhibitor-in-development
Medrx-company
Alto-neuroscience-inc
Medrx-company-limited
News-release-dated-april
Collaboration-partner
Alto-neuroscience
Announces-positive-phase
Company-limited

Alto Neuroscience (ANRO) Reports Positive Phase 1 Results for ALTO-101

Alto Neuroscience (ANRO) Reports Positive Phase 1 Results for ALTO-101
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Amit-etkin
Alto-neuroscience-inc
Alto-neuroscience